-
Vornorexant, also
known by its
developmental code
names ORN-0829 and TS-142, is an
orexin antagonist medication which is
under development for the treatment...
-
development reported for
anxiety disorders and
panic disorder, up to
phase 2
Vornorexant (ORN-0829, TS-142) – dual OX1 and OX2
antagonist –
under development...
- SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Alixorexton ALKS-2680 Danavorexton...
- SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Alixorexton ALKS-2680 Danavorexton...
- SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Alixorexton ALKS-2680 Danavorexton...
- fatigue, dizziness, headache,
abdominal discomfort, and nightmares.
Vornorexant –
another investigational short-acting
orexin receptor antagonist List...
- SB-334867 SB-408124
Suvorexant TCS-1102
Tebideutorexant (JNJ-61393215)
Vornorexant (ORN-0829, TS-142) OX2 Agonists: AEX-19
Alixorexton ALKS-2680 Danavorexton...
-
earlier phases of elimination. The
investigational agents seltorexant and
vornorexant,
which are
still in
clinical trials, have
comparatively very
short half-lives...
-
antagonist Suvorexant (Belsomra) – dual OX1 and OX2
receptor antagonist Vornorexant (ORN-0829, TS-142) – dual OX1 and OX2
receptor antagonist ACT-335827...
- (MIN-202, JNJ,42847922, JNJ-922) –
selective OX2
receptor antagonist [4]
Vornorexant (ORN-0829, TS-142) – dual OX1 and OX2
receptor antagonist [5] Piromelatine...
